Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 reservoirs.

Roger J Pomerantz1

  • 1Dorrance H. Hamilton Laboratory, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. roger.j.pomerantz@mail.tju.edu

Clinics in Laboratory Medicine
|September 25, 2002
PubMed
Summary

High levels of Human Immunodeficiency Virus type 1 (HIV-1) replication drive disease progression. Combination therapies like highly active antiretroviral therapy (HAART) significantly reduce viral load, improving survival in developed nations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.

Gastroenterology·2020
Same author

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020
Same author

Reply to Lagier et al.

The Journal of infectious diseases·2017
Same author

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.

The Journal of infectious diseases·2016
Same author

Generation of retroviral particles for the spleen necrosis virus (SNV)-based vector system and their use in transduction of various cell types.

Cold Spring Harbor protocols·2010
Same author

Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis.

Virology journal·2009

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) establishes persistent, high-level replication in most infected individuals.
  • Active viral replication is a key determinant of HIV-1 disease progression and patient survival.
  • The clinically quiescent phase of HIV-1 infection is characterized by ongoing viral replication.

Purpose of the Study:

  • To underscore the critical role of active viral replication in HIV-1 pathogenesis.
  • To highlight the impact of combination antiretroviral therapy on viral load and clinical outcomes.

Main Methods:

  • This abstract is based on a review of existing research on HIV-1 replication and treatment.
  • Analysis of the correlation between viral replication levels and disease progression markers.
  • Evaluation of the effects of highly active antiretroviral therapy (HAART) on viral load.

Main Results:

  • Sustained high-level HIV-1 replication occurs throughout infection, including during clinical latency.
  • Viral replication levels directly correlate with disease progression and survival rates.
  • Highly active antiretroviral therapy (HAART) has led to significant reductions in viral replication, morbidity, and mortality.

Conclusions:

  • Controlling HIV-1 replication is paramount for managing disease progression.
  • Highly active antiretroviral therapy (HAART) represents a major advancement in improving outcomes for HIV-1-infected individuals.
  • Further research into HIV-1 pathogenesis and therapeutic strategies remains crucial.

Related Experiment Videos